Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects motor neurons and microglia with no effective treatment. Now, induced pluripotent stem cell (iPSC)-derived motor neurons and microglia offer a promising tool for ALS research. These models enable researchers to study ALS-relevant phenotypes in these cells, providing new insights into the cellular dysfunction underlying ALS and facilitating drug response prediction.
Download this whitepaper to discover how iPSC-derived models enable deeper exploration of ALS pathology, supporting the development of targeted therapies.
